Ti L, Dong H, Kerr T, Turje R B, Parashar S, Min J E, Montaner J, Wood E, Milloy M-J
St. Paul's Hospital, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
HIV Med. 2017 Sep;18(8):580-586. doi: 10.1111/hiv.12493. Epub 2017 Mar 19.
HIV treatment-as-prevention campaigns emphasize early diagnosis and immediate access to care and antiretroviral therapy for HIV-positive individuals in order to increase levels of plasma HIV RNA viral load (VL) suppression. However, the possible role of harm reduction-based programmes in this objective has not yet been well evaluated. The objective of the study was to examine the relationship between being a client of the Dr. Peter Centre (DPC; an HIV/AIDS-focused adult integrated health programme) and VL suppression among highly active antiretroviral therapy (HAART)-exposed HIV-positive people who use illicit drugs (PWUD) in Vancouver, Canada.
Data were derived from the AIDS Care Cohort to Evaluate Exposure to Survival Services (ACCESS) study, a study of a community-recruited cohort of HIV-positive PWUD. A marginal structural model using inverse probability of treatment weights was used to estimate the longitudinal relationship between being a DPC client and exhibiting a VL < 50 HIV-1 RNA copies/mL plasma.
Between 2005 and 2014, 746 HAART-exposed participants were included in the study, of whom 269 (36.1%) reported being a DPC client at some time during the study period. A marginal structural model estimated a 1.54 greater odds of achieving VL suppression (95% confidence interval 1.20-1.99) among DPC clients.
Our findings demonstrate that participating in an innovative HIV/AIDS-focused adult integrated health programme that provides a broad range of clinical, harm reduction, and support services may contribute to optimizing the benefits of HAART in terms of morbidity, mortality and viral transmission among PWUD, and as a result help to fulfill the goals of the treatment-as-prevention strategy.
艾滋病治疗即预防运动强调对艾滋病毒呈阳性者进行早期诊断,并使其能立即获得护理和抗逆转录病毒治疗,以提高血浆艾滋病毒核糖核酸病毒载量(VL)抑制水平。然而,基于减少伤害的项目在这一目标中可能发挥的作用尚未得到充分评估。本研究的目的是在加拿大温哥华,调查使用非法药物的艾滋病毒呈阳性者(PWUD)中,成为彼得医生中心(DPC;一个以艾滋病毒/艾滋病为重点的成人综合健康项目)的服务对象与病毒载量抑制之间的关系,这些人接受了高效抗逆转录病毒治疗(HAART)。
数据来源于“评估生存服务暴露的艾滋病护理队列”(ACCESS)研究,该研究对一个通过社区招募的艾滋病毒呈阳性的PWUD队列进行了研究。使用治疗权重的逆概率的边际结构模型来估计成为DPC服务对象与血浆中艾滋病毒-1核糖核酸拷贝数<50/mL时病毒载量抑制之间的纵向关系。
2005年至2014年期间,746名接受HAART治疗的参与者被纳入研究,其中269人(36.1%)报告在研究期间的某个时间成为DPC的服务对象。边际结构模型估计,DPC服务对象实现病毒载量抑制的几率高1.54倍(95%置信区间1.20 - 1.99)。
我们的研究结果表明,参与一个以艾滋病毒/艾滋病为重点的创新型成人综合健康项目,该项目提供广泛的临床、减少伤害和支持服务,可能有助于在发病率、死亡率和病毒传播方面优化HAART对PWUD的益处,从而有助于实现治疗即预防战略的目标。